Developing the nation's biosimilars program

N Engl J Med. 2011 Aug 4;365(5):385-8. doi: 10.1056/NEJMp1107285.
No abstract available

MeSH terms

  • Biological Products*
  • Government Regulation
  • Legislation, Drug*
  • Molecular Structure
  • Therapeutic Equivalency*
  • United States
  • United States Food and Drug Administration

Substances

  • Biological Products